D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $24 Price Target

Benzinga · 2d ago
D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $24 price target.